CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis

Journal of Immunology

Volumn 169, Issue 6, 2002, Pages 3180-3190

  Mencacci, Antonella ^a   Montagnoli, Claudia ^a   Bacci, Angela ^a   Cenci, Elio ^a   Pitzurra, Lucia ^a   Spreca, Antonio ^a   Kopf, Manfred ^a   Sharpe, Arlene H ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FUNGUS HYPHAE; FUNGUS IMMUNITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037105471     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.6.3180     Document Type: Article

References (68)

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
2. Measurement of candidacidal activity of specific leukocytes types in mixed populations: Normal myeloperoxidase deficient and chronic granulomatous disease neutrophils
3. In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism
4. Fungal infections complicating acute leukemia
5. + Th subset selection in mice candidiasis
6. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice
7. A possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in cytokine dysregulated patterns of AIDS patients
8. Release of Candida albicans yeast antigens upon interaction with human neutrophils in vivo
9. Initiation of T helper cell immunity to Candida albicans by IL-12: The role of neutrophils
10. Biological role of helper T-cell subsets in candidiasis
11. Evolving risk factors for invasive fungal infections: All neutropenic patients are not the same
12. Chronic systemic candidiasis
13. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: The pathogenetic role of the antileukemic regimen
14. Treatment of fungal infections in surgical patients using conventional antifungals
15. + T cell responses by dysregulating antigen-presenting cell maturation
16. + T cells
17. Tumor-induced immune dysfunctions caused by myeloid suppressor cells
18. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide
19. Involvement of nitric oxide in bone-marrow-derived natural suppressor activity
20. Natural suppressor (NS) cells, neonatal tolerance and total lymphoid irradiation: Exploring obscure relationships
21. T-cell subsets and suppressor cells in human bone marrow
22. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
23. Wheat germ agglutinin positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity
24. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
25. Interferon-γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
26. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-γ
27. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact
28. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation
29. + T cells
30. Costimulatory regulation of T cell function
31. Human polymorphonuclear neutrophils express a B7-1-like molecule
32. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: Implications for initiation of Th immunity in vitro and in vivo
33. Defective antifungal T-helper 1 (TH1) immunity a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists
34. + stem cells: A new option for leukemia patients without an HLA-matched donor
35. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor
36. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells
37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
38. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes
39. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin V
40. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice
41. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
42. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection
43. Mouse type 1 IFN-producing cells are immature APCs with plasmacytoid morphology
44. + cells in the spleen of cyclophosphamide-treated mice: Implications for T-cell responses in immunosuppressed mice
45. + cells
46. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide: Genetic variations and dependence on IFN-γ
47. Immunosuppression induced by attenuated Salmonella: Evidence for mediation by macrophage precursors
48. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins
49. + T cell proliferation via an IFN-γ and nitric oxide-dependent mechanism
50. Murine graft-versus-host disease across minor barriers: Immunosuppressive aspects of natural suppressor cells
51. Other functions, other genes: Alternative activation of antigen-presenting cells
52. + T cells in vitro
53. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen
54. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells
55. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28
56. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation
57. L
58. + T lymphocytic cell lines primed by HIV envelope proteins
59. Differential regulation of nitric oxide synthase-2 and arginase-1 by type1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of 1-arginine metabolism
60. A negative regulatory function of B7 revealed in B7-1 transgenic mice
61. Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5
62. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections
63. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-a double-deficient mice infected with Candida albicans
64. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type 1 responses
65. Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice with Histoplasma capsulatum
66. Immunotherapy in patients with systemic mycoses: A promising adjunct
67. Postgrafting administration of granulocyte colony-stimulatitag factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants